NEWS AND EVENTS

NEWS

Year

11/24/2020

Sanifit to Participate in Upcoming Investor Conferences in December 2020

11/10/2020

Subgroup Analyses from Sanifit’s CaLIPSO Phase 2b Clinical Study Published in Kidney International Reports

11/02/2020

Sanifit to Participate at Upcoming Investor Conferences in November 2020

10/22/2020

Sanifit Presents New Data for SNF472 in Treatment of Vascular Calcification at ASN Kidney Week 2020

10/12/2020

Sanifit to Present New Data on SNF472 for Vascular Calcification at the American Society of Nephrology Kidney Week 2020

08/20/2020

Sanifit Appoints Adam Levy as Chief Financial Officer

08/06/2020

Biotech innovation in Spain: the European Investment Bank provides €20 million in financing to Sanifit to develop treatments for vascular calcification

07/20/2020

Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease

06/25/2020

SNF472 Mechanism of Action data published in British Journal of Pharmacology

06/01/2020

Sanifit Enhances Leadership Team with New Executive Appointments

04/07/2020

SNF472 featured in AHA Journal’s Circulation on the Run podcast

02/13/2020

First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis

EVENTS

Year

13th - 16th January - JPMorgan, San Francisco, USA

23rd - 25th March - Bio Europe Spring, Paris, France

16th - 19th June - European Calcified Tissue Society Congress, Marseille, France

2nd - 4th February - Jefferies Virtual Healthcare Conference, San Diego, USA

6th - 9th June - ERA-EDTA, Milan, Italy

20th - 25th October - ASN Kidney Week, Virtual

26th - 28th October - BIO Europe, Virtual

9th - 12th November - Credit Suisse 29th Annual Healthcare Conference, Virtual

17th - 19th November - Jefferies Virtual Healthcare Conference,

30th November - Piper Sandler 32nd Annual Healthcare Conference, Virtual

1st - 3rd December - Evercore Healthcare Conference, Virtual